Tag: #covid-19

UK Phase I trial finds AI-designed coronavirus vaccine candidate safe and elicits cross-reactive immune responses

Phase I UK trial: an AI-designed DNA vaccine for sarbecoviruses was safe in 39 adults and induced cross-reactive immune responses, but not proof it protects.

#covid-19, #vaccine, #clinicaltrials, #ai

EMA Recommends COVID-19 Vaccines Be Updated to Target XFG for 2026–27 Campaign

EMA’s Emergency Task Force recommends updating COVID-19 vaccines to target the XFG variant for the 2026–2027 season, guiding EU manufacturers and health authorities.

#covid-19, #ema, #vaccines, #xfg